z-logo
open-access-imgOpen Access
Cyclosporine Treatment in Severe Gestational Pemphigoid
Author(s) -
Laura Huilaja,
Kaarin Mäkikallio,
Katariina Hannula-Jouppi,
Liisa Väkevä,
Johanna HöökNikanne,
Kaisa Tasanen
Publication year - 2014
Publication title -
acta dermato venereologica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.982
H-Index - 83
eISSN - 1651-2057
pISSN - 0001-5555
DOI - 10.2340/00015555-2032
Subject(s) - medicine , bullous pemphigoid , itching , dermatology , pemphigoid , pregnancy , autoantibody , gestation , immunology , antibody , genetics , biology
Gestational pemphigoid, a rare autoimmune skin disease typically occurring during pregnancy, is caused by autoantibodies against collagen XVII. Clinically it is characterised by severe itching followed by erythematous and bullous lesions of the skin. Topical or oral glucocorticoids usually relieve symptoms, but in more severe cases systemic immunosuppressive treatments are needed. Data on immunosuppressive medication controlling gestational pemphigoid are sparse. We report 3 intractable cases of gestational pemphigoid treated with cyclosporine.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom